Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04036032 · ClinicalTrials.gov registry record
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
A clinical trial of Cancer and Cardiotoxicity, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 47
- Enrollment target
- 2
- Study locations
NCT04036032 is a study of Cancer and Cardiotoxicity that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 47 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04036032, a study of Cancer and Cardiotoxicity, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
- 2
- Study locations
Study Summary
Over 50% of the more than 270,000 childhood cancer survivors in the U.S. have been treated with anthracyclines and thus are at risk of developing cardiotoxicity. The impact of exercise training on LV structure has been extensively studied. Left ventricular hypertrophy and cardiac chamber enlargement with the accompanying ability to generate a large stroke volume are direct results of exercise training. Aerobic exercise therapy offers a non-pharmacological mechanism to modulate multiple gene expression pathways that may promote cardiac remodeling. No prior studies have investigated the efficacy of aerobic exercise in the prevention or treatment of anthracycline-induced cardiotoxicity. We hypothesize that exercise intervention leads to a reverse in adverse cardiac remodeling with improvement of global and regional myocardial function in patients exposed to anthracycline.
Conditions Studied
Interventions
- OTHER Exercise program
Study Locations (2)
Connecticut
- CT Children's Medical Center - Hartford
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-06-19 |
| Est. Completion | 2025-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04036032
The ClinicalTrials.gov registry entry for NCT04036032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise program is the first listed.
NCT04036032 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Ohio.
Frequently Asked Questions
What is clinical trial NCT04036032 about?
NCT04036032 is a clinical study titled "Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy". Over 50% of the more than 270,000 childhood cancer survivors in the U.S. have been treated with anthracyclines and thus are at risk of developing cardiotoxicity. The impact of exercise training on LV structure has been extensively studied. Left ventricular hypertrophy and cardiac chamber enlargement...
What is the current status of trial NCT04036032?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2015-06-19. Estimated completion is 2025-08-27.
What conditions does trial NCT04036032 study?
This clinical trial studies the following conditions: Cancer, Cardiotoxicity.
What interventions are being tested in trial NCT04036032?
The interventions under investigation include: Exercise program (OTHER).
Who is sponsoring clinical trial NCT04036032?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04036032 being conducted?
This trial has 2 study locations across Connecticut, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.